A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
Rob J. Van Geest, Sarit Y. Lesnik-Oberstein, H. Stevie Tan, Marco Mura, Roel Goldschmeding, Cornelis J.F. Van Noorden, Ingeborg Klaassen, Reinier O. Schlingemann
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy'. Together they form a unique fingerprint.